{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1196.495","meta":{"versionId":"16","lastUpdated":"2021-09-09T01:01:05.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Elimu Informatics Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-09-09"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1196.495"}],"version":"20210909","name":"ICSLABALAMAPreparations","title":"ICS LABA LAMA Preparations","status":"active","experimental":false,"date":"2021-09-09T01:01:05-04:00","publisher":"NHLBI Implementation Science and Health Care Innovation Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with a long-acting beta agonist and a long-acting muscarinic antagonist that may be used for maintenance controller therapy in adult asthmatics.  As of Sept 2020, the oral inhalant combination of fluticasone furoate + umeclidinium + vilanterol is indicated for the maintenance treatment of asthma in patients aged 18 years and older.),(Data Element Scope: FHIR \nMedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes fluticasone/umeclidinium/vilanterol oral inhalation preparations),(Exclusion Criteria: none)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1945039","display":"14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"},{"code":"1945044","display":"14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"},{"code":"1945047","display":"30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"},{"code":"1945048","display":"30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"}]}]},"expansion":{"identifier":"urn:uuid:9ea9717a-5ac3-4350-92c4-c88b9a26c952","timestamp":"2023-12-10T23:12:57-05:00","total":4,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1945039","display":"14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1945044","display":"14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1945047","display":"30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1945048","display":"30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"}]}}